Skip to content
PICO Portalanswers from OpenAlex

Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis

PaperCitations, authors & open-access status

Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis is a paper indexed in PICO Portal from OpenAlex.

How many citations does Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis have?

PICO Portalcitation count

Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis has 28 citations in the OpenAlex counts PICO Portal stores.

When was Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis published?

PICO Portalyear

Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis has 2012 year in the PICO Portal index.

What is the open-access status of Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis?

PICO Portaloa status

Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis has bronze oa status in the PICO Portal index.

What is the DOI of Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis?

PICO Portaldoi

The DOI for Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis is on the source record.

What is the PMID of Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis?

PICO Portalpmid

The PMID for Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis is on the source record.

What is the OpenAlex record for Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis?

PICO Portalopenalex

The OpenAlex for Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial